FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Habermann

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Bridget Charbonneau; Zachary S Fredericksen; Thomas M Habermann; Mark Liebow; William R Macon; Helen M O'Connor; Susan L Slager; Carrie A Thompson; Alice H Wang; Timothy G Call; James R Cerhan
Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma.
Jennifer L Kelly; Mark Liebow; William R Macon; Tait D Shanafelt; Susan L Slager; Carrie A Thompson; Alice H Wang; Timothy G Call; Zachary S Fredericksen; Thomas M Habermann; James R Cerhan
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.
Seher Iqbal; Geoffrey B Johnson; Paul J Kurtin; Zachary S DePew; Eric S Edell; Thomas M Habermann; Anne-Marie G Sykes; Fabien Maldonado
Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Habermann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bridget Charbonneau; Zachary S Fredericksen; Thomas M Habermann; Mark Liebow; William R Macon; Helen M O'Connor; Susan L Slager; Carrie A Thompson; Alice H Wang; Timothy G Call; James R Cerhan
Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma.
The Journal of nutrition 2013;143(5):672-81.
2012: Jennifer L Kelly; Mark Liebow; William R Macon; Tait D Shanafelt; Susan L Slager; Carrie A Thompson; Alice H Wang; Timothy G Call; Zachary S Fredericksen; Thomas M Habermann; James R Cerhan
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.
Annals of epidemiology 2012;22(12):855-62.
2012: Seher Iqbal; Geoffrey B Johnson; Paul J Kurtin; Zachary S DePew; Eric S Edell; Thomas M Habermann; Anne-Marie G Sykes; Fabien Maldonado
Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study.
The Annals of thoracic surgery 2012;94(6):1830-4.
2012: Bridget Charbonneau; Zachary S Fredericksen; Thomas M Habermann; Brian K Link; William R Macon; Matthew J Maurer; Stephen M Ansell; James R Cerhan; Susan L Slager; Thomas E Witzig; Steven C Ziesmer; Anne J Novak
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.
Cytokine 2012;60(3):882-9.
2012: Angela Dispenzieri; Ahmet Dogan; Susan M Geyer; Matt J Loe; David M Menke; Kay M Ristow; Dennis D Weisenburger; Jake Allred; James O Armitage; John K Camoriano; Thomas M Habermann
The clinical spectrum of Castleman's disease.
American journal of hematology 2012;87(11):997-1002.
2012: Luis F Porrata; Kay M Ristow; Carrie Thompson; Thomas E Witzig; Ivana N M Micallef; Grzegorz S Nowakowski; Nazan Ozsan; Stephen M Ansell; Joseph P Colgan; Ahmet Dogan; Thomas M Habermann; David J Inwards; Patrick B Johnston; William R Macon; Svetomir N Markovic
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.
Leukemia & lymphoma 2012;53(11):2159-65.
2012: James R Cerhan; Julie M Cunningham; Ahmet Dogan; Zachary S Fredericksen; Thomas M Habermann; Neil E Kay; Mark Liebow; Anne J Novak; Stephen M Ansell; Yan W Asmann; Alice H Wang; Thomas E Witzig; Susan L Slager
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1799-806.
2012: Bridget Charbonneau; Ahmet Dogan; Zachary S Fredericksen; Thomas M Habermann; Brian K Link; Matthew J Maurer; Anne J Novak; Susan L Slager; Alice H Wang; George J Weiner; Thomas E Witzig; Clive S Zent; Stephen M Ansell; James R Cerhan
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
American journal of hematology 2012;87(9):880-5.
2012: Jacob P Smeltzer; David S Viswanatha; Thomas M Habermann; Mrinal M Patnaik
Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
American journal of hematology 2012;87(9):927-8.
2012: Stephen M Ansell; James R Cerhan; Ahmet Dogan; Thomas M Habermann; Brian K Link; William R Macon; Matthew J Maurer; Susan L Slager; Thomas E Witzig; Steven C Ziesmer; Anne J Novak
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
American journal of hematology 2012;87(9):865-9.
2012: Shernan G Holtan; Mark Liebow; William R Macon; Ivana N M Micallef; Helen M O'Connor; Susan L Slager; Carrie A Thompson; Alice H Wang; Timothy G Call; Zachary S Fredericksen; Thomas M Habermann; James R Cerhan
Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma.
International journal of cancer. Journal international du cancer 2012;131(5):1158-68.
2012: Jennifer L Kelly; Mark Liebow; William R Macon; Grzegorz S Nowakowski; Tait D Shanafelt; Susan L Slager; Alice H Wang; Thomas E Witzig; Stephen M Ansell; Yan W Asmann; Timothy G Call; Matthew T Drake; Andrew L Feldman; Zachary S Fredericksen; Thomas M Habermann; Megan M Herr; James R Cerhan
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.
Cancer causes & control : CCC 2012;23(7):1017-29.
2012: James R Cerhan; STEPHEN CHANOCK; Wendy Cozen; Ahmet Dogan; Thomas M Habermann; Patricia Hartge; Izidore S Lossos; Charles F Lynch; Matthew J Maurer; Lindsay M Morton; Yasodha Natkunam; Nathaniel Rothman; Susan L Slager; Mohammad A Vasef; Cristine Allmer; Yan Asmann; Sophia S Wang
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
Leukemia & lymphoma 2012;53(6):1105-12.
2012: Luis F Porrata; Kay M Ristow; Carrie Thompson; Thomas E Witzig; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Ivana N M Micallef; Grzegorz S Nowakowski; Svetomir N Markovic
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
British journal of haematology 2012;157(3):321-30.
2012: Eoin P Flanagan; Thomas M Habermann; Brian Patrick O'Neill; Alyx B Porter; B Mark Keegan
Secondary intramedullary spinal cord non-Hodgkin's lymphoma.
Journal of neuro-oncology 2012;107(3):575-80.
2012: Thomas M Habermann
New developments in the management of diffuse large B-cell lymphoma.
Hematology (Amsterdam, Netherlands) 2012;17 Suppl 1():S93-7.
2012: Ryan A Wilcox; Thomas E Witzig; Kay M Ristow; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Grzegorz S Nowakowski; Luis F Porrata
The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma.
Leukemia & lymphoma 2012;53(4):575-80.
2012: Harris V K Naina; Mikel Prieto; S Vincent Rajkumar; Mark D Stegall; Fernando G Cosio; Patrick G Dean; Angela Dispenzieri; Thomas M Habermann; Samar Harris; Robert A Kyle; Nelson Leung
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
American journal of nephrology 2012;35(4):365-71.
2011: Carrie A Thompson; George J Weiner; Stephen M Ansell; James R Cerhan; Thomas M Habermann; Jerry A Katzmann; Brian K Link; William R Macon; Matthew J Maurer; Thomas E Witzig
Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.
American journal of hematology 2011;86(12):998-1000.
2011: Thomas E Witzig; Cristine Allmer; Stephen M Ansell; Joseph P Colgan; Husheng Ding; Mamta Gupta; Thomas M Habermann; Ray Hohl; David J Inwards; Patrick B Johnston; Paul J Kurtin; Brian K Link; David Loegering; Svetomir N Markovic; Matthew J Maurer; Ivana N M Micallef; Grzegorz S Nowakowski; Kevin Peterson; Luis F Porrata; Paula Schneider; Hui Tang; Carrie A Thompson; George Weiner; Scott H Kaufmann
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
Blood 2011;118(18):4882-9.
2011: Ivana N M Micallef; Daniel A Nikcevich; Domingo G Perez; Gamini S Soori; Gregory A Wiseman; Michael W Cannon; Thomas M Habermann; Paul J Kurtin; Brian K Link; Matthew J Maurer; Thomas E Witzig
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.
Blood 2011;118(15):4053-61.
2011: Nadia N Laack; Roscoe F Morton; Judith Rich O'Fallon; Brian Patrick O'Neill; Eduardo R Pajon; Bernd W Scheithauer; Harold E Windschitl; Karla V Ballman; Paul D Brown; Xiomara W Carrero; Joseph P Colgan; Tom R Fitch; Mark R Gilbert; Thomas M Habermann; Roland B Hawkins; Paul J Kurtin
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
International journal of radiation oncology, biology, physics 2011;81(2):476-82.
2011: Ryan A Wilcox; Thomas E Witzig; Kay M Ristow; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Grzegorz S Nowakowski; Luis F Porrata
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
Leukemia 2011;25(9):1502-9.
2011: Thomas M Habermann; Kanti Rai
Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses.
Leukemia & lymphoma 2011;52 Suppl 2():18-20.
2011: Thomas E Witzig; C B Reeder; B R LaPlant; M Gupta; Patrick B Johnston; Ivana N M Micallef; Luis F Porrata; Stephen M Ansell; Joseph P Colgan; E D Jacobsen; I M Ghobrial; Thomas M Habermann
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
Leukemia 2011;25(2):341-7.
2011: James Cerhan; Julie M Cunningham; Zachary S Fredericksen; Thomas M Habermann; Neil E Kay; William R Macon; Tait D Shanafelt; Susan L Slager; Alice H Wang; Thomas E Witzig; Stephen M Ansell; Timothy G Call; Mark Liebow
Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma.
International journal of molecular epidemiology and genetics 2011;2(2):95-113.
2010: Thorvardur R Halfdanarson; Alberto Rubio-Tapia; Kay M Ristow; Thomas M Habermann; Joseph A Murray; David J Inwards
Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(12):1042-7.
2010: Luis F Porrata; Kay M Ristow; Thomas M Habermann; David J Inwards; Ivana N M Micallef; Svetomir N Markovic
Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.
American journal of hematology 2010;85(11):896-9.
2010: Matthew T Drake; Matthew J Maurer; Brian K Link; Thomas M Habermann; Stephen M Ansell; Ivana N Micallef; Jennifer L Kelly; William R Macon; Grzegorz S Nowakowski; David J Inwards; Patrick B Johnston; Ravinder J Singh; Cristine Allmer; Susan L Slager; George J Weiner; Thomas E Witzig; James R Cerhan
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4191-8.
2010: Luis F Porrata; K Rsitow; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Thomas M Habermann; Thomas E Witzig; J P Colgan; Grzegorz S Nowakowski; C A Thompson; Svetomir N Markovic
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Leukemia 2010;24(7):1343-9.
2010: Susan M Geyer; Lindsay M Morton; Thomas M Habermann; Cristine Allmer; Scott Davis; Wendy Cozen; Richard K Severson; Charles F Lynch; Sophia S Wang; Matthew J Maurer; Patricia Hartge; James Cerhan
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
Cancer 2010;116(12):2993-3000.
2010: Patrick B Johnston; David J Inwards; Joseph P Colgan; Betsy R Laplant; Brian F Kabat; Thomas M Habermann; Ivana N M Micallef; Luis F Porrata; Stephen M Ansell; Craig B Reeder; Vivek Roy; Thomas E Witzig
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.
American journal of hematology 2010;85(5):320-4.
2010: Clive S Zent; Betsy R LaPlant; Patrick B Johnston; Timothy G Call; Thomas M Habermann; Ivana N M Micallef; Thomas E Witzig
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation.
Cancer 2010;116(9):2201-7.
2010: Alexandra Thomas; Roger D Gingrich; Brian J Smith; Laura Jacobus; Kay Ristow; Cristine Allmer; Matthew J Maurer; Thomas M Habermann; Brian K Link
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports.
Leukemia & lymphoma 2010;51(3):439-46.
2010: Carrie A Thompson; Thomas M Habermann; Alice H Wang; Robert A Vierkant; Aaron R Folsom; Julie A Ross; James R Cerhan
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study.
International journal of cancer. Journal international du cancer 2010;126(4):992-1003.
2010: Grzegorz S Nowakowski; Matthew J Maurer; Thomas M Habermann; Stephen M Ansell; William R Macon; Kay M Ristow; Cristine Allmer; Susan L Slager; Thomas E Witzig; James Cerhan
Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):412-7.
2009: Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.
American journal of hematology 2009;84(12):795-8.
2009: Colin P West; Angelina D Tan; Thomas M Habermann; Jeff A Sloan; Tait D Shanafelt
Association of resident fatigue and distress with perceived medical errors.
JAMA : the journal of the American Medical Association 2009;302(12):1294-300.
2009: N Issa; Hatem Amer; Patrick G Dean; Walter K Kremers; Yogish C Kudva; N Rostambeigi; Fernando G Cosio; Timothy S Larson; Thomas M Habermann; Mark D Stegall; Matthew D Griffin
Posttransplant lymphoproliferative disorder following pancreas transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(8):1894-902.
2009: James Cerhan; Anne J Novak; Zachary S Fredericksen; Alice H Wang; Mark Liebow; Timothy G Call; Ahmet Dogan; Thomas E Witzig; Stephen M Ansell; Thomas M Habermann; Neil E Kay; Susan L Slager
Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
British journal of haematology 2009;145(5):614-23.
2009: Thomas M Habermann; Izidore S Lossos; Glen Justice; Julie M Vose; Peter H Wiernik; Kyle McBride; Kenton Wride; Annette Ervin-Haynes; Kenichi Takeshita; Dennis Pietronigro; Jerome B Zeldis; Joseph M Tuscano
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
British journal of haematology 2009;145(3):344-9.
2009: Luis F Porrata; Kay M Ristow; Thomas M Habermann; Thomas E Witzig; David J Inwards; Svetomir N Markovic
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
American journal of hematology 2009;84(2):93-7.
2008: James Cerhan; Wen Liu; Zachary S Fredericksen; Anne J Novak; Julie M Cunningham; Neil E Kay; Ahmet Dogan; Mark Liebow; Alice H Wang; Timothy G Call; Thomas M Habermann; Stephen M Ansell; Susan L Slager
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(11):3161-9.
2008: Thomas M Habermann; Sophia S Wang; Matthew J Maurer; Lindsay Morton; Charles F Lynch; Stephen M Ansell; Patricia Hartge; Richard K Severson; Nathaniel Rothman; Scott Davis; Susan M Geyer; Wendy Cozen; STEPHEN CHANOCK; James Cerhan
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
Blood 2008;112(7):2694-702.
2008: Aisha Shaikh; Thomas M Habermann; Mary E Fidler; Shaji Kumar; Nelson Leung
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
Clinical and experimental nephrology 2008;12(4):292-5.
2008: Thomas M Habermann
Posttransplant lymphoproliferative disorders.
Cancer treatment and research 2008;142():273-92.
2007: James Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu; William R Macon; Diane F Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
Blood 2007;110(13):4455-63.
2007: Smitha Menon; Thomas M Habermann; Thomas E Witzig
Lenalidomide-associated hypothyroidism.
Leukemia & lymphoma 2007;48(12):2465-7.
2007: Luis F Porrata; Kay M Ristow; Thomas E Witzig; N Tuinistra; Thomas M Habermann; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Svetomir N Markovic
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
Leukemia 2007;21(12):2554-6.
2007: Kami Maddocks-Christianson; Susan L Slager; Clive S Zent; Megan S Reinalda; Timothy G Call; Thomas M Habermann; Deborah A Bowen; James D Hoyer; Susan Schwager; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
British journal of haematology 2007;139(3):398-404.
2007: Lijo Simpson; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Kay M Ristow; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Luis F Porrata; Thomas E Witzig
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Leukemia & lymphoma 2007;48(7):1332-7.
2007: James Cerhan; Sophia Wang; Matthew J Maurer; Stephen M Ansell; Susan M Geyer; Wendy Cozen; Lindsay Morton; Scott Davis; Richard K Severson; Nathaniel Rothman; Charles F Lynch; Sholom Wacholder; STEPHEN CHANOCK; Thomas M Habermann; Patricia Hartge
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
Blood 2007;109(12):5439-46.
2007: Thomas E Witzig; David J Inwards; Thomas M Habermann; Ahmet Dogan; Paul J Kurtin; John B Gross; Anuradha Ananthamurthy; Kay M Ristow; James A Garity
Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.
Mayo Clinic proceedings. Mayo Clinic 2007;82(6):692-9.
2007: Deepti Behl; Kay M Ristow; Svetomir N Markovic; Thomas E Witzig; Thomas M Habermann; Joseph P Colgan; David J Inwards; William L White; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Luis F Porrata
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
British journal of haematology 2007;137(5):409-15.
2007: Mikko Larsen; Thomas M Habermann; Allen T Bishop; Alexander Y Shin; Robert J Spinner
Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case report.
Journal of neurosurgery 2007;106(5):924-8.
2006: Ivana N M Micallef; Brad S Kahl; Matthew J Maurer; Ahmet Dogan; Stephen M Ansell; Joseph P Colgan; Susan Geyer; David J Inwards; William L White; Thomas M Habermann
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Cancer 2006;107(12):2826-32.
2006: Ivana N M Micallef; Ellen D Remstein; Stephen M Ansell; Joseph P Colgan; David J Inwards; Patrick B Johnston; Jason T Lewis; Svetomir N Markovic; Luis F Porrata; William L White; Thomas E Witzig; Kay M Ristow; Thomas M Habermann
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
Leukemia & lymphoma 2006;47(9):1794-9.
2006: Mustaqeem Siddiqui; Kay M Ristow; Svetomir N Markovic; Thomas E Witzig; Thomas M Habermann; Joseph P Colgan; David J Inwards; William L White; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Timothy G Call; Luis F Porrata
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
British journal of haematology 2006;134(6):596-601.
2006: Ted R Mikuls; Justin O Endo; Susan E Puumala; Patricia A Aoun; Natalie A Black; James R O'Dell; Julie A Stoner; Eugene C Boilesen; Martin Bast; Debra A Bergman; Kay M Ristow; Melissa Ooi; James O Armitage; Thomas M Habermann
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1597-602.
2005: Rebecca F McClure; Ellen D Remstein; William R Macon; Gordon W Dewald; Thomas M Habermann; Antje Hoering; Paul J Kurtin
Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
The American journal of surgical pathology 2005;29(12):1652-60.
2005: Irene M Ghobrial; Thomas M Habermann; Matthew J Maurer; Susan M Geyer; Kay M Ristow; Timothy S Larson; Randall C Walker; Stephen M Ansell; William R Macon; Gregory G Gores; Mark D Stegall; Christopher G A McGregor
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7574-82.
2005: William G Martin; Kay M Ristow; Thomas M Habermann; Joseph P Colgan; Thomas E Witzig; Stephen M Ansell
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7614-20.
2005: Thomas E Witzig; Allen M Vukov; Thomas M Habermann; Susan Geyer; Paul J Kurtin; William R Friedenberg; William L White; Haji I Chalchal; Patrick J Flynn; Tom R Fitch; Debra A Welker
Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1103-8.
2005: Irene M Ghobrial; Thomas M Habermann; Kay M Ristow; Stephen M Ansell; William R Macon; Susan M Geyer; Christopher G A McGregor
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.
Leukemia & lymphoma 2005;46(2):191-6.
2005: Irene M Ghobrial; Thomas M Habermann; William R Macon; Kay M Ristow; Timothy S Larson; Randall C Walker; Stephen M Ansell; Gregory J Gores; Mark D Stegall; Christopher G A McGregor
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?
Transplantation 2005;79(2):244-7.
2005: Lourdes Peña de la Vega; Fernando C Fervenza; Donna J Lager; Thomas M Habermann; Nelson Leung
Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium.
Renal failure 2005;27(4):485-9.
2004: Anne J Novak; Deanna M Grote; Mary J Stenson; Steven C Ziesmer; Thomas E Witzig; Thomas M Habermann; Brandon Harder; Kay M Ristow; Richard J Bram; Diane F Jelinek; Jane A Gross; Stephen M Ansell
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Blood 2004;104(8):2247-53.
2004: Irene M Ghobrial; Robert C Wolf; Denise Pereira; Rafael Fonseca; William L White; Joseph P Colgan; Thomas M Habermann; David J Inwards; Svetomir N Markovic; Stephen M Ansell; Ivana N M Micallef; Luis F Porrata; Thomas E Witzig
Therapeutic options in patients with lymphoma and severe liver dysfunction.
Mayo Clinic proceedings. Mayo Clinic 2004;79(2):169-75.
2002: Stephen M Ansell; Kay M Ristow; Thomas M Habermann; Gregory A Wiseman; Thomas E Witzig
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3885-90.
2002: Stephen M Ansell; Thomas E Witzig; Paul J Kurtin; Jeff A Sloan; Diane F Jelinek; Kyle G Howell; Svetomir N Markovic; Thomas M Habermann; George G Klee; Pamela J Atherton; Charles Erlichman
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma.
Blood 2002;99(1):67-74.
2001: Y Yoong; Paul J Kurtin; Cristine Allmer; S Geyer; Thomas M Habermann; D M Nagorney; Thomas E Witzig
Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma.
Leukemia & lymphoma 2001;42(6):1235-41.
2001: W J Hogan; W D Edwards; W R Macon; Thomas M Habermann
Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
Leukemia & lymphoma 2001;42(5):1145-50.
2001: Stephen M Ansell; Mary J Stenson; Thomas M Habermann; Diane F Jelinek; Thomas E Witzig
Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):720-6.
2000: Thomas M Habermann; David P Steensma
Lymphadenopathy.
Mayo Clinic proceedings. Mayo Clinic 2000;75(7):723-32.
2000: Rafael Fonseca; Thomas M Habermann; Joseph P Colgan; Brian Patrick O'Neill; William L White; Thomas E Witzig; Kathleen S Egan; James A Martenson; Lawrence J Burgart; David J Inwards
Testicular lymphoma is associated with a high incidence of extranodal recurrence.
Cancer 2000;88(1):154-61.
1999: B P O'Neill; Thomas M Habermann; Thomas E Witzig; M Rodriguez
Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone.
Medical oncology (Northwood, London, England) 1999;16(3):211-5.
1999: Stephen M Ansell; P J Kurtin; Mary J Stenson; Thomas M Habermann; Philip R Greipp; Terry M Therneau; Thomas E Witzig
Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.
Leukemia & lymphoma 1999;34(5-6):529-37.
1998: JG Strickler; John H Donohue; L E Porter; Thomas M Habermann
Laparoscopic biopsy for suspected abdominal lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(9):831-6.
1998: Thomas E Witzig; John K Camoriano; Georgene Schroeder; Paul J Kurtin; Thomas M Habermann
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;28(3-4):307-14.
1997: Stephen M Ansell; Thomas M Habermann; J D Hoyer; JG Strickler; Michael G Chen; T J McDonald
Primary laryngeal lymphoma.
The Laryngoscope 1997;107(11 Pt 1):1502-6.
1997: Stephen M Ansell; Thomas M Habermann; Paul J Kurtin; Thomas E Witzig; Michael G Chen; Chin-Yang Li; David J Inwards; Joseph P Colgan
Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2296-301.
1996: David M Menke; Markus Tiemann; John K Camoriano; S F Chang; A Madan; M Chow; Thomas M Habermann; R Parwaresch
Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
American journal of clinical pathology 1996;105(3):268-76.
1996: D R Salamao; A G Nascimento; R V Lloyd; Michael G Chen; Thomas M Habermann; JG Strickler
Lymphoma in soft tissue: a clinicopathologic study of 19 cases.
Human pathology 1996;27(3):253-7.
1995: Thomas E Witzig; Thomas M Habermann; Paul J Kurtin; Georgene Schroeder; M J Stenson; Philip R Greipp
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
Cancer 1995;76(6):1059-64.
1995: Brian Patrick O'Neill; Robert P Dinapoli; Paul J Kurtin; Thomas M Habermann
Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
Journal of neuro-oncology 1995;25(1):67-71.
1995: E D Durr; James A. Bonner; J G Strickler; James A Martenson; Michael G Chen; Thomas M Habermann; J H Donohue; John D Earle; Joseph P Grill
Management of stage IE primary gastric lymphoma.
Acta haematologica 1995;94(2):59-68.
1994: Paul J Kurtin; D J DiCaudo; Thomas M Habermann; Michael G Chen; W P Su
Primary cutaneous large cell lymphomas. Morphologic, immunophenotypic, and clinical features of 20 cases.
The American journal of surgical pathology 1994;18(12):1183-91.
1994: D K Kaufman; Thomas M Habermann; Paul J Kurtin; Brian Patrick O'Neill
Neurological complications of peripheral and cutaneous T-cell lymphomas.
Annals of neurology 1994;36(4):625-9.
1994: Joseph P Colgan; J Andersen; Thomas M Habermann; John D Earle; M J O'Connell; R S Neiman; R B Mann; J H Glick
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
Leukemia & lymphoma 1994;15(3-4):291-6.
1994: T G Call; Robert L Phyliky; P Noël; Thomas M Habermann; C M Beard; W Michael O'Fallon; L T Kurland
Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis.
Mayo Clinic proceedings. Mayo Clinic 1994;69(4):323-8.
1994: T G Call; P Noël; Thomas M Habermann; C M Beard; W Michael O'Fallon; L T Kurland
Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989.
Mayo Clinic proceedings. Mayo Clinic 1994;69(4):315-22.
1992: Paul J Kurtin; T A Gaffey; Thomas M Habermann
Peripheral T-cell lymphoma involving the placenta.
Cancer 1992;70(12):2963-8.
1992: C M Pyke; Clive S Grant; Thomas M Habermann; Paul J Kurtin; Jon A. van Heerden; Erik J Bergstralh; A Kunselman; Ian D Hay
Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary?
World journal of surgery 1992;16(4):604-9; discussion 609-10.
1992: Louis Letendre; H Clark Hoagland; S B Moore; Michael G Chen; Dennis A Gastineau; Morie A Gertz; Thomas M Habermann; Mark R Litzow; P Noël; Lawrence Solberg
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990.
Mayo Clinic proceedings. Mayo Clinic 1992;67(2):109-16.
1991: David J Inwards; D G Piepgras; J T Lie; Brian Patrick O'Neill; B W Scheithauer; Thomas M Habermann
Granulomatous angiitis of the spinal cord associated with Hodgkin's disease.
Cancer 1991;68(6):1318-22.
1990: David J Inwards; Thomas M Habermann; P M Banks; Joseph P Colgan; Gordon W Dewald
Cytogenetic findings in 21 cases of peripheral T-cell lymphoma.
American journal of hematology 1990;35(2):88-95.
1990: Thomas E Witzig; P M Banks; M J Stenson; P R Griepp; Jerry A Katzmann; Thomas M Habermann; Joseph P Colgan; N J Gonchoroff
Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.
American journal of clinical pathology 1990;94(3):280-6.
1989: Brian Patrick O'Neill; Thomas M Habermann; P M Banks; J R O'Fallon; J D Earle
Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia.
Cancer 1989;64(6):1296-300.
1989: Thomas E Witzig; N J Gonchoroff; Philip R Greipp; Jerry A Katzmann; M J Stenson; Thomas M Habermann; Joseph P Colgan; Terry M Therneau; P M Banks
Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.
American journal of clinical pathology 1989;91(3):298-301.
1987: Philip R Greipp; Thomas E Witzig; N J Gonchoroff; Thomas M Habermann; Jerry A Katzmann; W M O'Fallon; R A Kyle
Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.
Mayo Clinic proceedings. Mayo Clinic 1987;62(11):969-77.